| Print
IO Biotech (IOBT)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Address
Forecast key dates
| Name | Key Date |
|---|---|
| IO Biotech Inc Third Quarter Earnings Results for 2026 | 2026-11-13T00:00:00 |
| IO Biotech Inc Second Quarter Earnings Results for 2026 | 2026-08-14T00:00:00 |
| IO Biotech Inc Annual General Meeting for 2026 | 2026-06-05T08:30:00 |
| IO Biotech Inc First Quarter Earnings Results for 2026 | 2026-05-14T00:00:00 |
| IO Biotech Inc Annual Report for 2025 | 2026-03-31T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Piper Sandler 36th Annual Healthcare Conference | 2025-12-03T15:00:00 |
| 8 th Annual Evercore Healthcare Conference | 2025-12-02T07:55:00 |
| Global Healthcare Conference | 2025-11-18T15:00:00 |
| IO Biotech Inc Third Quarter Earnings Results for 2025 | 2025-11-14T00:00:00 |
| H.C. Wainwright 27th Annual Global Investment Conference | 2025-09-10T08:00:00 |
| Morgan Stanley 23rd Annual Global Healthcare Conference | 2025-09-09T07:45:00 |
| IO Biotech Inc Second Quarter Earnings Results for 2025 | 2025-08-14T00:00:00 |
| IO Biotech Inc Annual General Meeting for 2025 | 2025-06-05T08:30:00 |
| Jefferies Global Healthcare Conference | 2025-06-04T07:35:00 |
| TD Cowen 6th Annual Oncology Summit: Insights for ASCO & EHA | 2025-05-27T10:30:00 |
| IO Biotech Inc First Quarter Earnings Results for 2025 | 2025-05-14T00:00:00 |
| IO Biotech Inc Annual Report for 2024 | 2025-03-31T00:00:00 |
| 45th Annual Cowen Health Care Conference | 2025-03-05T14:30:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.